To determine the role of METTL7B in tumorigenesis and tumor development, we explored relationships between METTL7B and clinic-pathological features of gliomas, including WHO grade, IDH status, IDH/codel subtype. This evidence concerns the gene IDH1 and central nervous system cancer.